Search Results 671-680 of 8022 for TNF

  1. Michael T. Barrett, Ph.D. - Mayo Clinic Faculty Profiles

    D., is to comprehensively study the clonal evolution of neoplasia and cancer in patients who are at risk of or have already progressed to malignant disease. The ...

  2. A Study to Compare Compact 3T, Conventional 3T, and 7T Scanners Using Task Based and Resting State fMRI - Mayo Clinic

    About this study. The dual purposes of this study are to determine whether the increased performance of the Compact 3T scanner produces higher quality data ...

  3. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...

  4. Thyroid Autoimmune Dysfunction Due to Immune Checkpoint Inhibitors - Mayo Clinic

    About this study. The primary objective is to characterize the immune cell phenotypes in thyroid fine needle aspirates (FNA) and the peripheral blood of ...

  5. A Study of Genes that are Responsible for the Development of Disorders of Fibrosis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Supportive Care Needs and Resource Assessment in Cancer Patients - Mayo Clinic

    This study is investigating the supportive care needs, and levels of social support and distress, in adult patients who are receiving or have recently completed ...

  7. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  8. A Study to Evaluate Ischemia in Women to Reduce Non-obstructive CAD Events - Mayo Clinic

    The purpose of this trial is to determine whether aggressive medication treatment to modify risk factors in women with coronary arteries showing no severe ...

  9. A Study to Evaluate the Role of WNT/b-catenin Signaling in Human Alveolar Macrophages (AMs) in Adjusting Inflammation - Mayo Clinic

    We will also probe underlying respiratory and circulating immunological mechanisms contributing to the differences of disease severity between pediatric and ...

  10. A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical Treatment CTEPH - Mayo Clinic

    A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical ...